Clotting of the Extracorporeal Circuit in Hemodialysis: Beyond Contact-Activated Coagulation

Extracorporeal Coagulation system
DOI: 10.1016/j.semnephrol.2023.151473 Publication Date: 2024-01-21T05:47:00Z
ABSTRACT
Thrombotic complications in patients with end-stage kidney disease are frequent. While being a lifesaving treatment for these patients, hemodialysis introduces a thromboinflammatory environment. Additionally, the extracorporeal hemodialysis circuit itself is prone to clotting because of an interaction between different activation mechanisms of the coagulation system, platelets, and the immune system. Anticoagulation of the patient and the machine is frequently complicated by bleeding. We discuss the factors important in this balancing act and touch on potential strategies that are on the horizon to target thromboinflammation.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (82)
CITATIONS (7)